Clinical Trials in Pennsylvania

Showing 8041-8060 of 14,950 trials

Alglucosidase Alfa Pompe Safety Sub-Registry

NCT01710813

To collect uniform and meaningful data on patients with Pompe disease who experience anaphylaxis, severe allergic reactions, and/or signals of severe cutaneous and/or systemic immune complex-mediated reactions following treatment with alglucosidase alfa.

Pompe Disease

Genzyme, a Sanofi Company110 participantsStarted Mar 2015

Phoenix, Arizona, United States • Durham, North Carolina, United States • Hershey, Pennsylvania, United States +15 more locations

UNKNOWNPhase 295 miles

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

NCT02771509

The objective of the study is to assess the safety and efficacy of ANG-3777 in preventing AKI compared to placebo when administered to patients at risk for developing acute kidney injury (AKI) following cardiac surgical procedures involving cardiopulmonary bypass (CPB).

Acute Kidney Injury

Angion Biomedica Corp275 participantsStarted Feb 2017

Los Angeles, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +37 more locations

Alglucosidase Alfa Pompe Safety Sub-Registry

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

Find Trials by Condition in Pennsylvania

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

Long-term Effect of Lanthanum Carbonate on Bone

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Functional Epiphora Management Via Different Dacryocystorhinostomy (DCR) Techniques

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy